Exelixis coverage begins at Leerink Partners with Market Perform rating and $55 target
EXEL•Leerink Partners assumed coverage of Exelixis with a Market Perform rating and a $55 target price.
Related News
Coursera: BMO cuts target price to $6 from $8
COUR•
SailPoint, Inc.: Scotiabank raises target price to $24 from $22
SAIL•
Nurix, Gilead extend research term for oncology program by two years for $10 million fee
NRIX•
inTest expects Q3 revenue at high end of $33 million-$35 million guidance range
INTT•
Avery Dennison Chief Legal Officer Ignacio J. Walker resigns effective Oct. 16
AVY•